TNF and inflammatory bowel disease: Recently, a prospective cohort study demonstrated that anti-TNF agents shifted the diversity of gut microbiota in patients with IBD toward that of healthy individuals [57], suggesting that anti-TNF agents might prevent neuroinflammation via modulating the gut microbiota in the pathogenesis of neurodegenerative diseases.